Click for best price
ChemotherapyInduced Nausea Vomiting Drugs Market Size, Share 2022
Market Analysis and Insights: Global ChemotherapyInduced Nausea Vomiting Drugs Market
The global ChemotherapyInduced Nausea Vomiting Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global ChemotherapyInduced Nausea Vomiting Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global ChemotherapyInduced Nausea Vomiting Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global ChemotherapyInduced Nausea Vomiting Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global ChemotherapyInduced Nausea Vomiting Drugs market.
Global ChemotherapyInduced Nausea Vomiting Drugs Scope and Market Size
Chemotherapy-Induced Nausea and Vomiting Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Chemotherapy-Induced Nausea and Vomiting Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Chemotherapy-Induced Nausea and Vomiting Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
Segment by Application
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes ChemotherapyInduced Nausea Vomiting Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of ChemotherapyInduced Nausea Vomiting Drugs, with price, sales, revenue, and global market share of ChemotherapyInduced Nausea Vomiting Drugs from 2019 to 2022.
Chapter 3, the ChemotherapyInduced Nausea Vomiting Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the ChemotherapyInduced Nausea Vomiting Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the ChemotherapyInduced Nausea Vomiting Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of ChemotherapyInduced Nausea Vomiting Drugs.
Chapter 13, 14, and 15, to describe ChemotherapyInduced Nausea Vomiting Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 ChemotherapyInduced Nausea Vomiting Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
109 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Product Introduction
1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume for the Year 2017-2028
1.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume for the Year 2017-2028
1.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Chemotherapy-Induced Nausea and Vomiting Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Chemotherapy-Induced Nausea and Vomiting Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Chemotherapy-Induced Nausea and Vomiting Drugs Market Dynamics
1.5.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Trends
1.5.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
1.5.3 Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
1.5.4 Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment by Type
2.1.1 Existing Drugs
2.1.2 Akynzeo (Netupitant-Palonosetron FDC)
2.1.3 Aloxi (Palonosetron)
2.1.4 Emend (Aprepitant)
2.1.5 Kytril Generic (Granisetron)
2.1.6 Zofran Generic (Ondansetron)
2.1.7 Pipeline Drugs
2.1.8 SUSTOL (Granisetron Injection extended release)
2.1.9 Rolapitant
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
2.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type
2.3.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Segment by Application
3.1.1 Serotonin Receptor Antagonists
3.1.2 NK1 Receptor Antagonists
3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
3.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application
3.3.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Competitor Landscape by Company
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Company
4.1.1 Top Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Manufacturer (2017-2022)
4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Concentration Ratio (CR)
4.2.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Chemotherapy-Induced Nausea and Vomiting Drugs in 2021
4.2.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Chemotherapy-Induced Nausea and Vomiting Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Company
4.5.1 Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Players (2020, 2021 & 2022)
5 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region
5.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Corporation Information
7.1.2 Merck & Co., Inc. Description and Business Overview
7.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.1.5 Merck & Co., Inc. Recent Development
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Corporation Information
7.2.2 GlaxoSmithKline plc Description and Business Overview
7.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.2.5 GlaxoSmithKline plc Recent Development
7.3 Tesaro, Inc.
7.3.1 Tesaro, Inc. Corporation Information
7.3.2 Tesaro, Inc. Description and Business Overview
7.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.3.5 Tesaro, Inc. Recent Development
7.4 Helsinn Group
7.4.1 Helsinn Group Corporation Information
7.4.2 Helsinn Group Description and Business Overview
7.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.4.5 Helsinn Group Recent Development
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
7.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
7.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.5.5 F. Hoffmann-La Roche Ltd. Recent Development
7.6 Heron Therapeutics, Inc.
7.6.1 Heron Therapeutics, Inc. Corporation Information
7.6.2 Heron Therapeutics, Inc. Description and Business Overview
7.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.6.5 Heron Therapeutics, Inc. Recent Development
7.7 Dr. Reddy's Laboratories Ltd.
7.7.1 Dr. Reddy's Laboratories Ltd. Corporation Information
7.7.2 Dr. Reddy's Laboratories Ltd. Description and Business Overview
7.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.7.5 Dr. Reddy's Laboratories Ltd. Recent Development
7.8 Acacia Pharma
7.8.1 Acacia Pharma Corporation Information
7.8.2 Acacia Pharma Description and Business Overview
7.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.8.5 Acacia Pharma Recent Development
7.9 Sun Pharmaceutical Industry Ltd.
7.9.1 Sun Pharmaceutical Industry Ltd. Corporation Information
7.9.2 Sun Pharmaceutical Industry Ltd. Description and Business Overview
7.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.9.5 Sun Pharmaceutical Industry Ltd. Recent Development
7.10 Otsuka Holdings Co., Ltd.
7.10.1 Otsuka Holdings Co., Ltd. Corporation Information
7.10.2 Otsuka Holdings Co., Ltd. Description and Business Overview
7.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Products Offered
7.10.5 Otsuka Holdings Co., Ltd. Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industry Chain Analysis
8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors
8.3 Chemotherapy-Induced Nausea and Vomiting Drugs Production Mode & Process
8.4 Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Marketing
8.4.1 Chemotherapy-Induced Nausea and Vomiting Drugs Sales Channels
8.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Distributors
8.5 Chemotherapy-Induced Nausea and Vomiting Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chemotherapy-Induced Nausea and Vomiting Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Chemotherapy-Induced Nausea and Vomiting Drugs Market Trends
Table 3. Chemotherapy-Induced Nausea and Vomiting Drugs Market Drivers
Table 4. Chemotherapy-Induced Nausea and Vomiting Drugs Market Challenges
Table 5. Chemotherapy-Induced Nausea and Vomiting Drugs Market Restraints
Table 6. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Chemotherapy-Induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting Drugs as of 2021)
Table 18. Top Players of Chemotherapy-Induced Nausea and Vomiting Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Chemotherapy-Induced Nausea and Vomiting Drugs Product Type
Table 20. Date of International Manufacturers Enter into Chemotherapy-Induced Nausea and Vomiting Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Chemotherapy-Induced Nausea and Vomiting Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Merck & Co., Inc. Corporation Information
Table 43. Merck & Co., Inc. Description and Business Overview
Table 44. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product
Table 46. Merck & Co., Inc. Recent Development
Table 47. GlaxoSmithKline plc Corporation Information
Table 48. GlaxoSmithKline plc Description and Business Overview
Table 49. GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. GlaxoSmithKline plc Product
Table 51. GlaxoSmithKline plc Recent Development
Table 52. Tesaro, Inc. Corporation Information
Table 53. Tesaro, Inc. Description and Business Overview
Table 54. Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. Tesaro, Inc. Product
Table 56. Tesaro, Inc. Recent Development
Table 57. Helsinn Group Corporation Information
Table 58. Helsinn Group Description and Business Overview
Table 59. Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Helsinn Group Product
Table 61. Helsinn Group Recent Development
Table 62. F. Hoffmann-La Roche Ltd. Corporation Information
Table 63. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 64. F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. F. Hoffmann-La Roche Ltd. Product
Table 66. F. Hoffmann-La Roche Ltd. Recent Development
Table 67. Heron Therapeutics, Inc. Corporation Information
Table 68. Heron Therapeutics, Inc. Description and Business Overview
Table 69. Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Heron Therapeutics, Inc. Product
Table 71. Heron Therapeutics, Inc. Recent Development
Table 72. Dr. Reddy's Laboratories Ltd. Corporation Information
Table 73. Dr. Reddy's Laboratories Ltd. Description and Business Overview
Table 74. Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Dr. Reddy's Laboratories Ltd. Product
Table 76. Dr. Reddy's Laboratories Ltd. Recent Development
Table 77. Acacia Pharma Corporation Information
Table 78. Acacia Pharma Description and Business Overview
Table 79. Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Acacia Pharma Product
Table 81. Acacia Pharma Recent Development
Table 82. Sun Pharmaceutical Industry Ltd. Corporation Information
Table 83. Sun Pharmaceutical Industry Ltd. Description and Business Overview
Table 84. Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Sun Pharmaceutical Industry Ltd. Product
Table 86. Sun Pharmaceutical Industry Ltd. Recent Development
Table 87. Otsuka Holdings Co., Ltd. Corporation Information
Table 88. Otsuka Holdings Co., Ltd. Description and Business Overview
Table 89. Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Otsuka Holdings Co., Ltd. Product
Table 91. Otsuka Holdings Co., Ltd. Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Chemotherapy-Induced Nausea and Vomiting Drugs Customers List
Table 95. Chemotherapy-Induced Nausea and Vomiting Drugs Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotherapy-Induced Nausea and Vomiting Drugs Product Picture
Figure 2. Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2028 (K Units)
Figure 5. United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales 2017-2028 (K Units)
Figure 8. United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Chemotherapy-Induced Nausea and Vomiting Drugs Report Years Considered
Figure 11. Product Picture of Existing Drugs
Figure 12. Product Picture of Akynzeo (Netupitant-Palonosetron FDC)
Figure 13. Product Picture of Aloxi (Palonosetron)
Figure 14. Product Picture of Emend (Aprepitant)
Figure 15. Product Picture of Kytril Generic (Granisetron)
Figure 16. Product Picture of Zofran Generic (Ondansetron)
Figure 17. Product Picture of Pipeline Drugs
Figure 18. Product Picture of SUSTOL (Granisetron Injection extended release)
Figure 19. Product Picture of Rolapitant
Figure 20. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type in 2022 & 2028
Figure 21. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in Value by Type (2017-2028)
Figure 23. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028) & (K Units)
Figure 24. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 25. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 26. United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Type in 2022 & 2028
Figure 27. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 28. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in Value by Type (2017-2028)
Figure 29. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Type (2017-2028) & (K Units)
Figure 30. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 31. United States Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 32. Product Picture of Serotonin Receptor Antagonists
Figure 33. Product Picture of NK1 Receptor Antagonists
Figure 34. Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Application in 2022 & 2028
Figure 35. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in Value by Application (2017-2028)
Figure 37. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028) & (K Units)
Figure 38. Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 39. Global Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 40. United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Share by Application in 2022 & 2028
Figure 41. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 42. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in Value by Application (2017-2028)
Figure 43. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales by Application (2017-2028) & (K Units)
Figure 44. United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 45. United States Chemotherapy-Induced Nausea and Vomiting Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 46. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. North America Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. U.S. Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Canada Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Europe Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. Germany Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. France Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. U.K. Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Italy Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Russia Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 58. Asia-Pacific Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 59. China Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Japan Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. South Korea Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. India Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Australia Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Taiwan Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Indonesia Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Thailand Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Malaysia Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Philippines Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 70. Latin America Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Mexico Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Brazil Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Argentina Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 75. Middle East & Africa Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 76. Turkey Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. U.A.E Chemotherapy-Induced Nausea and Vomiting Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 79. Chemotherapy-Induced Nausea and Vomiting Drugs Value Chain
Figure 80. Chemotherapy-Induced Nausea and Vomiting Drugs Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
